Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882

Watchlist Manager
Guangzhou Kingmed Diagnostics Group Co Ltd Logo
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Watchlist
Price: 28.72 CNY 0.67% Market Closed
Market Cap: 13.3B CNY

Guangzhou Kingmed Diagnostics Group Co Ltd
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Guangzhou Kingmed Diagnostics Group Co Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Revenue
ÂĄ6.1B
CAGR 3-Years
-27%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Jinxin Fertility Group Ltd
HKEX:1951
Revenue
ÂĄ2.8B
CAGR 3-Years
15%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Topchoice Medical Co Inc
SSE:600763
Revenue
ÂĄ2.9B
CAGR 3-Years
2%
CAGR 5-Years
8%
CAGR 10-Years
15%
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
Revenue
ÂĄ6.6B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
-8%
Dian Diagnostics Group Co Ltd
SZSE:300244
Revenue
ÂĄ10.5B
CAGR 3-Years
-18%
CAGR 5-Years
2%
CAGR 10-Years
20%
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
Revenue
ÂĄ10.5B
CAGR 3-Years
5%
CAGR 5-Years
9%
CAGR 10-Years
19%
No Stocks Found

Guangzhou Kingmed Diagnostics Group Co Ltd
Glance View

Market Cap
13.3B CNY
Industry
Health Care

Guangzhou Kingmed Diagnostics Group Co Ltd has crafted its journey in the healthcare industry with precision and analytical prowess. Emerging in the early 2000s, Kingmed Diagnostics tapped into a burgeoning market niche—offering diagnostic testing services to hospitals, clinics, and other medical institutions. With a blend of advanced technology and extensive scientific expertise, the company provides a range of services, from routine clinical testing to esoteric evaluations that require more sophisticated techniques. Kingmed’s laboratories, strategically established across China, facilitate a seamless operation that processes millions of tests annually, ensuring timely and accurate results. This operational efficiency not only supports healthcare providers in delivering informed patient care but also positions Kingmed at the forefront of diagnostic innovation. Revenue streams flow through service contracts with healthcare facilities and direct partnerships where they provide specialized testing offerings that institutions may not have the infrastructure to perform in-house. By leveraging economies of scale, Kingmed achieves cost efficiencies, which in turn afford competitive pricing structures, further securing its market position. Complementing its robust diagnostic services, the company also invests in research and development initiatives, continuously enhancing its test portfolio. This commitment to innovation ensures that they stay relevant in the ever-evolving healthcare landscape, capturing new opportunities and expanding their market reach. Through this strategic framework, Guangzhou Kingmed Diagnostics not only sustains its financial growth but also fortifies its leadership in the diagnostic services sector.

Intrinsic Value
29.46 CNY
Undervaluation 3%
Intrinsic Value
Price

See Also

What is Guangzhou Kingmed Diagnostics Group Co Ltd's Revenue?
Revenue
6.1B CNY

Based on the financial report for Sep 30, 2025, Guangzhou Kingmed Diagnostics Group Co Ltd's Revenue amounts to 6.1B CNY.

What is Guangzhou Kingmed Diagnostics Group Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
-3%

Over the last year, the Revenue growth was -22%. The average annual Revenue growth rates for Guangzhou Kingmed Diagnostics Group Co Ltd have been -27% over the past three years , -3% over the past five years .

Back to Top